COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 551: Articles 5501-5510  | Next

Cumulative COVID-19 incidence indicators should account for the population-at-risk dynamics
Masjuan, P., Trias-Llimos, S., Rojas, C., Prakash, A., Gullon, P., Tobias, A., Lopez-Gay, A.
10.1101/2022.10.18.22281225 — Posted: 2022-10-20
ALCOHOLIC LIVER BIOMARKERS: DETERMINANTS FOR ADMISSION TO REHABILITATION CENTRES DURING THE COVID 19 PERIOD IN KENYA
NJOROGE, G., MWENDA, C., MECHA, E., WAITHAKA, S.
10.1101/2022.10.18.22281212 — Posted: 2022-10-20
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN COURSE AMID COVID-19 PANDEMIC IN THE REBUBLIC OF BELARUS
Romanova, O., Kolomiets, N., Savitski, D., Dashkevich, A. M., Krasko, O., Batyan, G., Kluchareva, A., Sokolova, M., Sergienko, E., Hanenko, O., Matush, L., Senkevich, U.
10.1101/2022.10.14.22280869 — Posted: 2022-10-20
Alternative splicing in the lung influences COVID-19 severity and respiratory diseases.
Nakanishi, T., Yossi Farjoun, Y., Willett, J. D. S., Allen, R. J., Guillen-Guio, B., Zhou, S., Richards, J. B.
10.1101/2022.10.18.22281202 — Posted: 2022-10-20
SARS-CoV-2 infected cells sprout actin-rich filopodia that facilitate viral invasion
Jiu, Y., Zhang, Y., Zhang, X., Li, Z., Yang, H., Tang, D., Zhao, S., Zhang, Q., Li, B., Lappalainen, P., Cui, Z., Liu, H., Li, H., Zhao, W.
10.1101/2022.10.19.512957 — Posted: 2022-10-20
Altered infective competence of the human gut microbiome in COVID-19
de Nies, L., Galata, V., Martin-Gallausiaux, C., Despotovic, M., Busi, S. B., Snoeck, C. J., Delacour, L., Budagavi, D. P., Laczny, C. C., Habier, J., Lupu, P.-C., Halder, R., Fritz, J. V., Marques, T., Sandt, E., O'Sullivan, M. P., Ghosh, S., Satagopam, V., CON-VINCE Consortium, , Kruger, R., Fagherazzi, G., Ollert, M., Hefeng, F. Q., May, P., Wilmes, P.
10.1101/2022.10.20.512999 — Posted: 2022-10-20
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Qu, P., Evans, J. P., Faraone, J., Zheng, Y.-M., Carlin, C., Anghelina, M., Stevens, P., Fernandez, S., Jones, D., Lozanski, G., Panchal, A., Saif, L. J., Oltz, E. M., Xu, K., Gumina, R. J., Liu, S.-L.
10.1101/2022.10.19.512891 — Posted: 2022-10-20
Ancestral SARS-CoV-2 driven antibody repertoire diversity in an unvaccinated individual correlates with expanded neutralization breadth
Deshpande, S., Ansari, M. Y., Sutar, J., Das, P., Hingankar, N., Mukherjee, S., Jayal, P., Singh, S., Anantharaj, A., Singh, J., Chattopadhyay, S., Raghavan, S., Gosain, M., Chauhan, S., Shrivas, S., Prasad, C., Chauhan, S., Sharma, N., Jana, P., Thiruvengadam, R., Kshetrapal, P., Wadhwa, N., Das, B., Batra, G., Medigeshi, G. R., Sok, D., Bhatnagar, S., Garg, P., Bhattacharya, J.
10.1101/2022.10.19.512979 — Posted: 2022-10-20
SARS-CoV2 E and 3a proteins are inducers of pannexin currents
Oliveira Mendes, B., Alameh, M., Ollivier, B., Montnach, J., Bidere, N., Souaze, F., Escriou, N., Charpentier, F., Baro, I., De Waard, M., Loussouarn, G.
10.1101/2022.10.20.513002 — Posted: 2022-10-20
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Rouet, R., Henry, J. Y., Johansen, M. D., Sobti, M., Balachandran, H., Langley, D. B., Walker, G., Lenthall, H., Jackson, J., Ubiparipovic, S., Mazigi, O., Schofield, P., Burnett, D. L., Brown, S. H. J., Martinello, M., Hudson, B., Gilroy, N., Post, J. J., Kelleher, A., Jäck, H.-M., Goodnow, C., Turville, S. G., Rawlinson, W. D., Bull, R. A., Stewart, A. G., Hansbro, P. M., Christ, D.
10.1101/2022.10.19.512954 — Posted: 2022-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).